Qsart-B25 Tablet ER
Marketer
Quads Biotech Healthcare Private Limited
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (23.75mg)
Overview Qsart-B25 Tablet ER
B25 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking the medication with food daily, as directed by your physician; never discontinue without consulting your doctor, as high blood pressure is often asymptomatic. Lifestyle modifications—regular exercise, weight management, and a healthy diet—complement treatment. Side effects may include headache, weakness, dizziness, low blood pressure, elevated potassium, orthostatic hypotension (sometimes with fainting), shortness of breath, nausea, vomiting, abdominal pain, and fatigue. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any liver or kidney issues, or if you are pregnant or breastfeeding. Always disclose all medications, particularly those for hypertension or heart conditions.
Primary Ingredients of Qsart-B25 Tablet ER
No text provided. Please provide the text you want me to rephrase.
Uses of Qsart-B25 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Qsart-B25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Qsart-B25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Qsart-B25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Qsart-B25 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Qsart-B25 Extended-Release tablets should be taken with a meal.
How Qsart-B25 Tablet ER works:
Telmisartan and Metoprolol Succinate are combined in the extended-release Qsart-B25 Tablet to reduce blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Qsart-B25 Tablet ER is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Extended-release Qsart-B25 tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Qsart-B25 tablets appear to be safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Qsart-B25 tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects are experienced.
KidneySAFE IF PRESCRIBED
Qsart-B25 Extended-Release tablets can be administered safely to individuals with renal impairment. No alteration of the Qsart-B25 Extended-Release tablet dosage is necessary.
LiverCAUTION
Patients with hepatic impairment should use Qsart-B25 Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Qsart-B25 Tablet ER :
Should you forget to take a Qsart-B25 Tablet ER, administer it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Qsart-B25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
3,018 People bought this recently